This topic contains a solution. Click here to go to the answer

Author Question: While counseling a patient with cystic fibrosis who is beginning to use inhaled tobramycin, it is ... (Read 108 times)

dbose

  • Hero Member
  • *****
  • Posts: 597
While counseling a patient with cystic fibrosis who is beginning to use inhaled tobramycin, it is important to discuss the potential development of:
 
  1. hearing loss.
  2. reduced pulmonary function.
  3. tinnitus.
  4. bleeding.

Question 2

A patient is diagnosed with pulmonary arterial hypertension. Which nursing diagnosis would have the highest priority to add to the plan of care?
 
  1. Risk for decreased cardiac output
  2. Risk for impaired role performance
  3. Risk for a disturbed sleep pattern
  4. Risk for disturbed sensory perception



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bpool94

  • Sr. Member
  • ****
  • Posts: 354
Answer to Question 1

Correct Answer: 3

Answer to Question 2

Correct Answer: 1





 

Did you know?

The term bacteria was devised in the 19th century by German biologist Ferdinand Cohn. He based it on the Greek word "bakterion" meaning a small rod or staff. Cohn is considered to be the father of modern bacteriology.

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

If you could remove all of your skin, it would weigh up to 5 pounds.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

For a complete list of videos, visit our video library